LENZ Therapeutics (LENZ) Non Operating Income (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Non Operating Income data on file, last reported at $2.6 million in Q1 2026.

• On a quarterly basis, Non Operating Income rose 14.49% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 15.93% decrease from a year earlier, with the FY2025 full-year figure at $9.5 million, up 7.59% from the prior year.
• Non Operating Income for Q1 2026 stood at $2.6 million, up from $2.6 million in the prior quarter.
• Over the last five years, Non Operating Income for LENZ reached as high as $4.1 million in Q2 2024 and fell as low as -$560000.0 in Q1 2024.
• Historically, Non Operating Income has averaged $1.6 million across 5 years, with a median of $2.2 million in 2022.
• Across the five-year window, Non Operating Income soared 21420.0% in 2022 and tumbled 937.04% in 2024, its largest moves.
• Year by year, Non Operating Income stood at $2.2 million in 2022, then tumbled by 48.05% to $1.1 million in 2023, then soared by 130.23% to $2.6 million in 2024, then decreased by 0.19% to $2.6 million in 2025, then grew by 3.04% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.2 million in Q3 2025.